78 followers
BQ7876 he agent containing DOTA chelator was designed (BQ7876). The aim of the study was to test the hypothes https://t.co/cGW74VFg8R https://t.co/KQ4Sp6fUbQ
BQ7876 he agent containing DOTA chelator was designed (BQ7876). The aim of the study was to test the hypothes https://t.co/cGW74VFg8R https://t.co/KQ4Sp6fUbQ
RT @FrontOncology: New research: 177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate canc…
New research: 177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry: Introduction Prostate specific membrane antigen (PSMA), highly expressed… #oncology ht